Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

3.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.4K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.4K
Asthma I: Introduction01:28

Asthma I: Introduction

360
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
360
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

73
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
73

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progression of structural lung disease and lung function in adolescents with cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2025
Same author

Factors in childhood associated with lung function decline to adolescence in cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2022
Same author

Rare variant analysis in eczema identifies exonic variants in DUSP1, NOTCH4 and SLC9A4.

Nature communications·2021
Same author

Identification of pediatric bronchiolitis obliterans syndrome posthematopoietic stem cell transplantation; surveillance is the key.

Pediatric pulmonology·2020
Same author

Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort.

The European respiratory journal·2020
Same author

Viral induced hypersecretion of mucous (VIper).

Pediatric pulmonology·2019
Same journal

Corrigendum.

The Journal of allergy and clinical immunology·2026
Same journal

Comparative Efficacy of Biologic Agents for Severe Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Network Meta-analysis.

The Journal of allergy and clinical immunology·2026
Same journal

Tamoxifen-driven neutrophil reprogramming protects from pulmonary Granulibacter bethesdensis infection in chronic granulomatous disease.

The Journal of allergy and clinical immunology·2026
Same journal

Clinical and transcriptomic characterization of mixed granulocytic COPD phenotype.

The Journal of allergy and clinical immunology·2026
Same journal

Dupilumab outcomes in pediatric asthma by early eosinophil status: post hoc analysis of VOYAGE/EXCURSION.

The Journal of allergy and clinical immunology·2026
Same journal

Maternal antibiotic exposure alters the newborn metabolomic profile and increases the risk of respiratory infections in offspring: a 13-year longitudinal birth cohort study.

The Journal of allergy and clinical immunology·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 14, 2010

22.3K

The Melbourne Asthma Study: 1964-1999.

Peter D Phelan1, Colin F Robertson, Anthony Olinsky

  • 1Department of Respiratory Medicine, Royal Children's Hospital, University of Melbourne, Australia.

The Journal of Allergy and Clinical Immunology
|February 14, 2002
PubMed
Summary
This summary is machine-generated.

Most childhood wheezing resolves by adulthood, showing a benign course. However, persistent asthma symptoms in childhood often continue into adulthood, impacting lung function.

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 5, 2010

34.4K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

29.5K

Related Experiment Videos

Last Updated: May 6, 2026

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 14, 2010

22.3K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 5, 2010

34.4K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

29.5K

Area of Science:

  • Pediatrics
  • Respiratory Medicine
  • Epidemiology

Background:

  • Wheezing in childhood is common, but its long-term prognosis is variable.
  • Understanding the natural history of childhood wheezing is crucial for effective management.
  • Previous studies have not comprehensively tracked wheezing phenotypes into mid-adult life.

Purpose of the Study:

  • To investigate the long-term outcomes of childhood wheezing into adulthood.
  • To differentiate the course of episodic wheezing versus persistent childhood asthma.
  • To assess the impact of childhood wheezing and asthma on lung function over time.

Main Methods:

  • Prospective cohort study of children with wheezing from Melbourne.
  • Initial recruitment at ages 7 and 10 years (1964).
  • Follow-up at 7-year intervals until age 42 (1999), with 87% retention.

Main Results:

  • Majority of children with episodic wheezing (linked to respiratory infections) experienced resolution by adulthood.
  • Children with persistent asthma in childhood largely continued to wheeze significantly into adulthood.
  • Lung function decline was observed by age 14 in severe childhood asthma but did not progress in adulthood; milder symptoms showed no significant lung function loss.

Conclusions:

  • Childhood wheezing often has a benign prognosis, with many individuals outgrowing symptoms.
  • Persistent childhood asthma is associated with continued wheezing and potential lung function impairment into adult life.
  • Early childhood asthma severity predicts adult symptom burden and lung function trajectory, even without modern inhaled steroid treatments.